Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Licenses Geron's Patents on Human Embryonic Stem Cells

NEW YORK (GenomeWeb News) - Geron licensed its intellectual property related to the growth of human embryonic stem cells to Invitrogen, Invitrogen said today.
Under the non-exclusive license agreement, Invitrogen can use Geron's patents to develop, manufacture, and sell media, additives, and reagents for use by hESC researchers. Some commercial use restrictions apply.
Invitrogen can also sublicense the products to its customers for research use only. Geron will receive license payments and royalties on products developed using the patents.
The license involves patents covering the growth of hESCs in the absence of feeder cells, and those covering specific media formulations for such feeder-free growth.
Additional financial details were not disclosed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.